Henan Lingrui Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 10.32% vs 13.95% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 14.17% vs 13.87% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,126.10",
          "val2": "1,020.80",
          "chgp": "10.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "262.90",
          "val2": "259.20",
          "chgp": "1.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.50",
          "chgp": "60.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.80",
          "val2": "-0.40",
          "chgp": "300.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "247.40",
          "val2": "216.70",
          "chgp": "14.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "233.40%",
          "val2": "230.50%",
          "chgp": "0.29%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 10.40% vs 5.44% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 5.51% vs 27.20% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,814.80",
          "val2": "3,455.50",
          "chgp": "10.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "923.40",
          "val2": "798.90",
          "chgp": "15.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.10",
          "val2": "0.30",
          "chgp": "-2,466.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "762.40",
          "val2": "722.60",
          "chgp": "5.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "215.50%",
          "val2": "209.10%",
          "chgp": "0.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

1,126.10

1,020.80

10.32%

Operating Profit (PBDIT) excl Other Income

262.90

259.20

1.43%

Interest

0.80

0.50

60.00%

Exceptional Items

0.80

-0.40

300.00%

Consolidate Net Profit

247.40

216.70

14.17%

Operating Profit Margin (Excl OI)

233.40%

230.50%

0.29%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 10.32% vs 13.95% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 14.17% vs 13.87% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

3,814.80

3,455.50

10.40%

Operating Profit (PBDIT) excl Other Income

923.40

798.90

15.58%

Interest

0.70

0.70

Exceptional Items

-7.10

0.30

-2,466.67%

Consolidate Net Profit

762.40

722.60

5.51%

Operating Profit Margin (Excl OI)

215.50%

209.10%

0.64%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 10.40% vs 5.44% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 5.51% vs 27.20% in Dec 2024

All Annual Results